Polymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome

REFERENCES

• ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al.: Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–2533.
   PubMed Web of Science ®Google Scholar
• Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334–1349.
   PubMed Web of Science ®Google Scholar
• Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, et al.: Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med. 2010;181(10): 1121–1127.
   PubMed Web of Science ®Google Scholar
• Zambon M, Vincent JL: Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008;133(5):1120–1127.
   PubMed Web of Science ®Google Scholar
• Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, et al.: Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med. 2009;179(3):220–227.
   PubMed Web of Science ®Google Scholar
• Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD, Network NNA: Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med. 2009;37(5):1574–1579.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Ware LB, Zimmerman GA: The acute respiratory distress syndrome. The J Clin Invest. 2012;122(8):2731–2740.
   PubMed Web of Science ®Google Scholar
• Russell JA: Management of sepsis. N Engl J Med. 2006;355(16): 1699–1713.
   PubMed Web of Science ®Google Scholar
• Sturrock A, Seedahmed E, Mir-Kasimov M, Boltax J, McManus ML, Paine R, 3rd: GM-CSF provides autocrine protection for murine alveolar epithelial cells from oxidant-induced mitochondrial injury. Am J Physiol Lung Cell Mol Physiol. 2012;302(3):L343-51.
   PubMed Web of Science ®Google Scholar
• Paine R, 3rd, Wilcoxen SE, Morris SB, Sartori C, Baleeiro CE, Matthay MA, et al.: Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury. Am J Pathol. 2003;163(6):2397–2406.
   PubMed Web of Science ®Google Scholar
• Christensen PJ, Bailie MB, Goodman RE, O'Brien AD, Toews GB, Paine R, 3rd. Role of diminished epithelial GM-CSF in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L487–L95.
   PubMed Web of Science ®Google Scholar
• Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, et al. Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mol Biol. 2010;42(5):545–551.
   PubMed Web of Science ®Google Scholar
• Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al.: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. New England J Med. 2004;351(4):327–336.
   PubMed Web of Science ®Google Scholar
• National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wheeler AP, Bernard GR, Thompson BT, Schoenfeld D, et al.: Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. New England J Med. 2006;354(21):2213–2224.
   PubMed Web of Science ®Google Scholar
• National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, et al.: Comparison of two fluid-management strategies in acute lung injury. The New England J Med. 2006;354(24):2564–2575.
   PubMed Web of Science ®Google Scholar
• National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Matthay MA, Brower RG, Carson S, Douglas IS, et al.: Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Resp Crit Care Med. 2011;184(5):561–568.
   PubMed Web of Science ®Google Scholar
• Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, Christiani DC.: Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med. 2007;35(1):48–56.
   PubMed Web of Science ®Google Scholar
• Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC.: Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 2004;125(1):203–211.
   PubMed Web of Science ®Google Scholar
• Bernard GR.: Acute respiratory distress syndrome: a historical perspective. Am J Respir Crit Care Med. 2005;172(7):798–806.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al.: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818–824.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al.: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100(6):1619–1636.
   PubMed Web of Science ®Google Scholar
• Russell JA, Singer J, Bernard GR, Wheeler A, Fulkerson W, Hudson L, et al.: Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med. 2000;28(10):3405–3411.
   PubMed Web of Science ®Google Scholar
• Schoenfeld DA, Bernard GR: Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30(8):1772–1777.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodological). 1995;57(1):289–300.
   Google Scholar
• Benjamini Y, Yekutieli D: The control of the false discovery rate in multiple testing under dependency. 2001:1165–1188.
   Google Scholar
• Winham SJ, Motsinger-Reif AA: An R package implementation of multifactor dimensionality reduction. BioData Min. 2011;4(1):24.
   PubMedGoogle Scholar
• Friedman JH, Roosen CB: An introduction to multivariate adaptive regression splines. Stat Methods Med Res. 1995;4(3): 197–217.
   PubMedGoogle Scholar
• R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. 2009.
   Google Scholar
• Gauderman WJ, Morrison JM: QUANTO 1.2.4: A computer program for power and sample size calculations for genetic-epidemiology studies. 2009.
   Google Scholar
• Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, et al.: Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med. 2011;183(4): 462–470.
   PubMed Web of Science ®Google Scholar
• Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–311.
   PubMed Web of Science ®Google Scholar
• Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2006;19(11):1437–1445.
   Google Scholar
• Mukherjee TK, Mukhopadhyay S, Hoidal JR: Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol. 2008;162(3):210–215.
   PubMed Web of Science ®Google Scholar
• Shirasawa M, Fujiwara N, Hirabayashi S, Ohno H, Iida J, Makita K, et al.: Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Gene Cell : Dev Mol Cell Mech. 2004;9(2):165–174.
   PubMed Web of Science ®Google Scholar
• Briot R, Frank JA, Uchida T, Lee JW, Calfee CS, Matthay MA: Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009;135(2):269–275.
   PubMed Web of Science ®Google Scholar
• Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, et al.: Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008;63(12):1083–1089.
   PubMed Web of Science ®Google Scholar
• Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, van der Poll T, Hoidal JR, et al.: Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med. 2007;35(5):1369–1375.
   PubMed Web of Science ®Google Scholar
• Su X, Looney MR, Gupta N, Matthay MA: Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am J Physiol Lung Cell Mol Physiol. 2009;297(1):L1–5.
   PubMed Web of Science ®Google Scholar
• Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, et al.: Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006;290(4):L661–L73.
   PubMed Web of Science ®Google Scholar
• Huffman Reed JA, Rice WR, Zsengeller ZK, Wert SE, Dranoff G, Whitsett JA: GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol. 1997;273(4 Pt 1):L715–L725.
   PubMed Web of Science ®Google Scholar
• Paine R, 3rd, Morris SB, Jin H, Wilcoxen SE, Phare SM, Moore BB, et al.: Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2001;281(5):L1210–L1228.
   PubMed Web of Science ®Google Scholar
• Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC: GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity. 2001;15(4):557–567.
   PubMed Web of Science ®Google Scholar
• Trapnell BC, Whitsett JA, Nakata K: Pulmonary alveolar proteinosis. The New Engl J Med. 2003;349(26):2527–2539.
   PubMed Web of Science ®Google Scholar
• LeVine AM, Reed JA, Kurak KE, Cianciolo E, Whitsett JA: GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J Clin Invest. 1999;103(4): 563–569.
   PubMed Web of Science ®Google Scholar
• Paine R, 3rd, Preston AM, Wilcoxen S, Jin H, Siu BB, Morris SB, et al.: Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol. 2000;164(5):2602–2609.
   PubMed Web of Science ®Google Scholar
• LeVine AM, Reed JA, Kurak KE, Cianciolo E, Whitsett JA: GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. The J Clin Invest. 1999;103(4):563–569.
   PubMed Web of Science ®Google Scholar
• Paine R, 3rd, Preston AM, Wilcoxen S, Jin H, Siu BB, Morris SB, et al.: Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol. 2000;164(5):2602– 2609.
   PubMed Web of Science ®Google Scholar
• Huffman JA, Hull WM, Dranoff G, Mulligan RC, Whitsett JA: Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice [see comments]. J Clin Invest. 1996;97(3):649–655.
   PubMed Web of Science ®Google Scholar
• Huffman JA, Hull WM, Dranoff G, Mulligan RC, Whitsett JA: Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. The J Clin Invest. 1996;97(3):649–655.
   PubMed Web of Science ®Google Scholar
• Baleeiro CE, Christensen PJ, Morris SB, Mendez MP, Wilcoxen SE, Paine R, 3rd. GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress. American journal of physiology Lung cellular and molecular physiology. 2006;291(6):L1246–55.
   Google Scholar
• Moore BB, Coffey MJ, Christensen P, Sitterding S, Ngan R, Wilke CA, et al.: GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J Immunol. 2000;165(7):4032–4039.
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Liles WC, Radella F, 2nd, Steinberg KP, Ruzinski JT, Hudson LD, et al.: Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med. 2000;28(1):1–7.
   PubMed Web of Science ®Google Scholar
• Paine R, 3rd, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg AL, et al.: A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med. 2012;40(1): 90–97.
   PubMed Web of Science ®Google Scholar
• Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, et al.: Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell aMol Biol. 2006;34(4):487–495.
   PubMed Web of Science ®Google Scholar
• Tejera P, Meyer NJ, Chen F, Feng R, Zhao Y, O'Mahony DS, et al.: Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin. J Med Gen. 2012;49(11):671–680.
   Google Scholar
• Dvir S, Velten L, Sharon E, Zeevi D, Carey LB, Weinberger A, et al.: Deciphering the rules by which 5’-UTR sequences affect protein expression in yeast. Proc Natl Acad Sci U S A. 2013;110(30):E2792–E2801.
   PubMed Web of Science ®Google Scholar
• Meijer HA, Kong YW, Lu WT, Wilczynska A, Spriggs RV, Robinson SW, et al.: Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science. 2013;340(6128):82–85.
   PubMed Web of Science ®Google Scholar
• Sturrock A, Mir-Kasimov M, Baker J, Rowley J, Paine R, 3rd: Key role of microRNA in the regulation of granulocyte macrophage colony-stimulating factor expression in murine alveolar epithelial cells during oxidative stress. J Biol Chem. 2014;289(7):4095–4105.
   PubMed Web of Science ®Google Scholar